To use all functions of this page, please activate cookies in your browser.
Cleaning craze in the brain
Synaptic protein waste" was collected more quickly when the presynaptic protein bassoon is missing
Synapses consist of hundreds of different proteins. For correct transmission of brain signals, their building blocks must constantly be checked for functionality and replaced by new ones. A team of researchers from the Leibniz Institute of Neurobiology Magdeburg, the German Centre for Neurodegenerative Diseases and the Charité Hospital in Berlin has investigated how the functioning of synapses in the brain is affected when the presynaptic protein bassoon is missing. They found out that the recycling process of synaptic proteins is much faster because an enzyme called Parkin is activated, which plays an important role in Parkinson's disease.
Previously, it was known that Parkin loss of function leads to Parkinson's disease. When Parkin is non-functional, aggregates of proteins accumulate in brain tissue that can no longer be degraded, which - as always when too much waste accumulates - impairs normal functions and eventually leads to complete functional failure due to cell death.
Cleaning up in the synapse
The team of authors around Dr. Carolina Montenegro and Prof. Dr. Eckart Gundelfinger from LIN as well as Dr. Sheila Hoffmann-Conaway and Prof. Dr. Craig C. Garner from the DZNE shows in the new study that exactly the opposite happens after the Bassoon protein is switched off: the "synaptic protein waste" was collected more quickly and the active proteins were younger than in the comparable controls. To find this out, the researchers added colour-coded tags to one of the proteins to be disposed of, called SV2. These tags change colour with age and act as a marker for the neuronal disposal processes. The SV2 protein gets incorporated into synaptic vesicles, the small containers that contain the neurotransmitters which are released during synaptic transmission. The ageing process of the active protein can be observed through the colour change. Under the electron microscope, further indications of increased disposal of cellular waste were found - a process known as autophagy. For example, a larger number of "waste containers", so-called autophagosomes could be detected in synapses when Bassoon is missing. The authors were able to show that in synapses without Bassoon, several proteins were increasingly marked for degradation. However, if the protein Parkin, which is defective in Parkinson's disease, was switched off, this process could be counteracted.
What do we learn from these experiments?
Synapses with altered Bassoon protein are weaker and cannot adapt so easily to changes, a feature which is essential for brain plasticity. "With our experiments, we better understand the processes in the synapses that are essential for the correct functioning of a healthy brain," says Dr. Carolina Montenegro. "All important brain processes, perceiving, thinking, learning, remembering, planning of actions, i.e. the entire information processing, are determined by synapses. With increasing age, the way they function changes, partly because such waste disposal processes no longer function properly. Particularly in brain diseases such as Alzheimer's or Parkinson's disease, disturbances in the balance between protein supply and disposal contribute to cognitive problems. In order to understand these diseases, and perhaps even to be able to intervene in a more targeted manner, we need to know exactly what goes wrong when a protein or its gene functions incorrectly or not at all."
Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Ludwig-Maximilians-Universität (LMU) Munich and Denali Therapeutics (South San Francisco, CA, USA)have developed an approach to stimulate immune cells of the brain in such a way that they might possibly provide bette ... more
LMU researchers Christian Haass and Michael Ewers have identified a factor that might possibly delay the emergence and slow the progression of Alzheimer’s disease. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the Institute for Stroke and Dementia Research (ISD) ... more
Scientists at the German Center for Neurodegenerative Diseases (DZNE) have identified a group of proteins that help to regenerate damaged nerve cells. It is commonly accepted that neurons of the central nervous system shut down their ability to grow when they no longer need it; this occurs ... more
The German Center for Neurodegenerative Diseases (DZNE) investigates the causes of diseases of the nervous system and develops strategies for prevention, treatment and care. It is an institution of the Helmholtz Association of German Research Centres with sites in Berlin, Bonn, Dresden, Göt ... more
Researchers from Charité – Universitätsmedizin Berlin and the Francis Crick Institute have identified 27 proteins which are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms. These biomarker profiles could be used to predict disease p ... more
A new diagnostic test to quickly and easily monitor kidney transplant patients for infection and rejection relies on a simple urine sample and a powerful partner: the gene-editing technology CRISPR. Michael Kaminski, who developed it, leads a new Emmy Noether Group at the MDC & Charité. The ... more
Scientists from the Berlin Institute of Health (BIH), Charité – Universitätsmedizin Berlin and the Thorax Clinic at Heidelberg University Hospital, whose collaboration is taking place under the auspices of the German Center for Lung Research (DZL), have examined samples from non-virus infec ... more
The Charité is one of the largest university hospitals in Europe. Here, 3800 doctors and scientists heal, do research and teach at the top international level. More than half of the German Nobel Prize winners in medicine and physiology come from the Charité, among them Emil von Behring, Ro ... more
- Hurdle of microscopy overcome
- New method leads ten times faster to corona test results
- Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
- HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors
- Marine alga from the Kiel Fjord discovered as a remedy against infections and skin cancer